Is It Time for Polypill in Heart Failure Therapy? Current Preference among Indian Cardiologists: A Cross-sectional Survey

Is It Time for Polypill in Heart Failure Therapy? Current Preference among Indian Cardiologists: A Cross-sectional Survey

Background and Aim:Quadruple therapy plays a key role in heart failure (HF) management and the latest recommendation is “four pillar drugs on board in 4 weeks.” At present, there is no fixed-dose combination (FDC) of these foundational therapies existing in India. The present study aimed to understa...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamal Sharma, Ajay Pandey, Prafulla Kerkar, Sameer Shrivastava, Satyanarayan Routray, Smit Shrivastava, Aziz Khan, Preethi Naik, Nitin Zalte, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Akhil Sharma, Johann Christopher, Rohith Reddy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
arni
beta-blockers
heart failure
quadruple therapy
sodium-glucose cotransporter 2 inhibitors
Online Access:https://journals.lww.com/10.4103/jpcs.jpcs_46_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/jpcs.jpcs_46_24

Similar Items